Assertion: codeine's use | /r/HasProperty | necessary
Facets:
Source sentences:
text: If concomitant use of a CYP3A4 inhibitor is necessary or if a CYP3A4 inducer is discontinued, consider dosage reduction of Codeine Sulfate Tablets until stable drug effects are achieved.
text: When combined use is needed, consider minimizing doses of one or more drugs.
text: If concomitant use of a CYP3A4 inducer is necessary or if a CYP3A4 inhibitor is discontinued, consider increasing the Codeine Sulfate Tablets dosage until stable drug effects are achieved.
text: If concomitant use with a CYP2D6 inhibitor is necessary, follow the patient for signs of reduced efficacy or opioid withdrawal and consider increasing the Codeine Sulfate Tablets dosage.
text: If concomitant use of a CYP3A4 inhibitor is necessary or if a CYP3A4 inducer is discontinued, consider dosage reduction of Acetaminophen and Codeine Phosphate tablets until stable drug effects are achieved.
text: If concomitant use of a CYP3A4 inducer is necessary or if a CYP3A4 inhibitor is discontinued, consider increasing the Acetaminophen and Codeine Phosphate tablets dosage until stable drug effects are achieved.
text: If concomitant use with a CYP2D6 inhibitor is necessary, follow the patient for signs of reduced efficacy or opioid withdrawal and consider increasing the Acetaminophen and Codeine Phosphate tablets dosage.
text: If concomitant use with a CYP2D6 inhibitor is necessary, or if a CYP2D6 inhibitor is discontinued after concomitant use, consider dosage adjustment of Acetaminophen and Codeine Phosphate tablets and monitor patients closely at frequent intervals.
text: If concomitant use with CYP2D6 inhibitors is necessary, follow the patient for reduced efficacy or signs and symptoms of opioid withdrawal and consider increasing the Acetaminophen and Codeine Phosphate tablets as needed.
text: If concomitant use of CYP3A4 inhibitor is necessary, consider dosage reduction of Acetaminophen and Codeine tablets until stable drug effects are achieved.
text: If concomitant use of a CYP3A4 inducer is necessary, follow the patient for reduced efficacy and signs of opioid withdrawal and consider increasing the Acetaminophen and Codeine Phosphate tablets dosage as needed.
text: If urgent use of an opioid is necessary, use test doses and frequent titration of small doses of other opioids (such as oxycodone, hydrocodone, oxymorphone, hydrocodone, or buprenorphine) to treat pain while closely monitoring blood pressure and signs and symptoms of CNS and respiratory depression.
text: If concomitant use of a CYP3A4 inhibitor is necessary or if a CYP3A4 inducer is discontinued, consider dosage reduction of Ascomp with Codeine until stable drug effects are achieved.
text: If concomitant use of a CYP3A4 inducer is necessary or if a CYP3A4 inhibitor is discontinued, consider increasing the Ascomp with Codeine dosage until stable drug effects are achieved.
text: If concomitant use with a CYP2D6 inhibitor is necessary, follow the patient for signs of reduced efficacy or opioid withdrawal and consider increasing the Ascomp with Codeine dosage.
text: If concomitant use of a CYP3A4 inhibitor is necessary or if a CYP3A4 inducer is discontinued, consider dosage reduction of TYLENOL® with Codeine until stable drug effects are achieved.
text: If concomitant use of a CYP3A4 inducer is necessary or if a CYP3A4 inhibitor is discontinued, consider increasing the TYLENOL® with Codeine dosage until stable drug effects are achieved.
text: If concomitant use with a CYP2D6 inhibitor is necessary, follow the patient for signs of reduced efficacy or opioid withdrawal and consider increasing the TYLENOL® with Codeine dosage.
text: If concomitant use with a CYP2D6 inhibitor is necessary, or if a CYP2D6 inhibitor is discontinued after concomitant use, consider dosage adjustment of TYLENOL® with Codeine and monitor patients closely at frequent intervals.
text: If concomitant use with CYP2D6 inhibitors is necessary, follow the patient for reduced efficacy or signs and symptoms of opioid withdrawal and consider increasing the dosage of TYLENOL® with Codeine as needed.
text: If concomitant use of CYP3A4 inhibitor is necessary, consider dosage reduction of TYLENOL® with Codeine until stable drug effects are achieved.
text: If concomitant use of a CYP3A4 inducer is necessary, follow the patient for reduced efficacy and signs of opioid withdrawal and consider increasing the TYLENOL® with Codeine dosage as needed.
text: If urgent use of an opioid is necessary, use test doses and frequent titration of small doses of other opioids (such as oxycodone, hydrocodone, oxymorphone, hydrocodone, or buprenorphine) to treat pain while closely monitoring blood pressure and signs and symptoms of CNS and respiratory depression.